AUS
NZ
UK
CA
USA
IND
_06_19_2026_12_34_15_139937.jpg)
Highlights
- Over the last five days, the S&P/ASX200 has gained 1.82% but is down 10.7% over the last 52 weeks
- The benchmark of the healthcare index, the S&P/ASX 200 Health Care, is down 11.16% over the last 52 weeks
- Paragon offers a generous dividend with an annual dividend yield of 5.42%.
The S&P/ASX200 is in the red today, slipping 49.10 points or 0.73% to 6,651.10. Over the last five days, the index has earned 1.88% but is down 9.10% over the last 52 weeks. Similarly, the benchmark of the healthcare index, the S&P/ASX 200 Health Care, is also in the red by 11.16% over the last 52 weeks.
This article will discuss three penny stocks from the ASX healthcare index and their recent market updates. These stocks have provided decent price returns to their shareholders in the last 52 weeks.
Data source: EODHD/Others as of 30 June 2022
Paragon Care Limited (ASX:PGC)
Paragon Care offers world-class technology and support to all healthcare sectors. The company’s four strategic pillars include Specialty Diagnostics, Specialty Devices, Capital & Consumables and Services & Technology.
In the half year ended 31 December 2021, Paragon reported a 20% growth in underlying Earnings Before Interest, Taxes, Depreciation & Amortisation (EBITDA). The gross profit margin for that period was 42%, and NPAT increased 4% compared to the previous corresponding period. Paragon also offers a generous dividend with an annual dividend yield of 5.42%.
Monash IVF Group Limited (ASX:MVF)
Image source: © Vadimgozhda | Megapixl.com
Monash IVF Group offers services of tertiary-level prenatal diagnostics and assisted reproductive technologies (ART). Based in Australia, the company expanded its business in Asia in 2012 by acquiring KL fertility in Malaysia.
Last month, Monash entered a binding sale agreement for the acquisition of a fertility services provider, PIVET Medical Centre, based in Perth. Based on FY2022 Adjusted Net Profit After Tax (NPAT) expectations of Monash, PIVET generates nearly $8 million in revenue every year and is projected to increase NPAT by nearly 4%.
Asian American Medical Group Limited (ASX:AJJ)
AJJ operates liver and radiation centres in Singapore. It also offers healthcare management and consultancy services for overseas healthcare projects and manages healthcare real estate.
In the half year ended 31 December 2021, AJJ reported a decline in revenue by 10.9%. Similarly, it incurred a net loss of S$622K.
In April, the company joined hands with the King’s College Hospital of London to set up the first standalone liver centre in China.
